Market Overview

The global Ophthalmic Viscoelastic Devices (OVD) market size reached USD 2.8 Billion in 2024 and is projected to reach USD 3.8 Billion by 2033. The market is expected to grow at a CAGR of 3.34% during the forecast period 2025-2033. Growth is driven by the increasing number of ophthalmic surgeries, extensive R&D activities, and the expanding healthcare industry. These devices protect ocular structures and facilitate various eye surgeries, enhancing surgical outcomes.

Study Assumption Years

• Base Year: 2024
• Historical Year/Period: 2019-2024
• Forecast Year/Period: 2025-2033

Ophthalmic Viscoelastic Devices (OVD) Market Key Takeaways

• Current Market Size: USD 2.8 Billion in 2024
• CAGR: 3.34% (2025-2033)
• Forecast Period: 2025-2033
• Ophthalmic viscoelastic devices are used widely in glaucoma, corneal transplant, vitreoretinal, and cataract surgeries for ocular protection and procedural facilitation.
• Cohesive ophthalmic viscoelastic held the largest product market share.
• Cataract surgery segment dominates applications.
• Hospitals constitute the largest end-user segment.
• North America is the largest regional market owing to R&D, aging population, and prevalence of ocular disorders.

Sample Request Link: https://www.imarcgroup.com/ophthalmic-viscoelastic-devices-market/requestsample

Market Growth Factors

The market of ophthalmic viscoelastic devices is mainly driven by the increasing number of ophthalmic surgeries performed globally. These devices have the main purpose of protecting and maintaining ocular structures. This improves the overall outcome of ophthalmic surgical procedures. However, their use for maintaining space, tissue stabilization, and avoiding trauma to surrounding tissues has increased in recent years.

Not only has the accessibility of ophthalmic care improved, but also awareness of eye problems and diagnoses has increased. This reinforces the demand since people accept and use viscoadaptive ophthalmic viscosurgical devices. Those devices combine the properties of cohesive and dispersive ophthalmic viscosurgical devices in a single syringe for easier use.

The market growth is attributed to driving factors such as the increasing geriatric population, increasing diabetic and age-related ocular disorders, the rapidly developing healthcare infrastructure, government initiatives for the prevention of vision loss, and the increasing healthcare expenditure are thus expected to drive market growth.

Market Segmentation

Product:

• Cohesive Ophthalmic Viscoelastic: Holds the largest market share due to its effectiveness in maintaining space during intraocular procedures.
• Dispersive Ophthalmic Viscoelastic: Used for protecting and stabilizing ocular tissues during surgeries.

Application:

• Cataract Surgery: The dominant application segment, representing the largest use of ophthalmic viscoelastic devices.
• Glaucoma Surgery: Utilized to protect ocular structures and facilitate surgery.
• Corneal Transplant: Applied during procedures to maintain tissue integrity.
• Vitreoretinal Surgery: Used to stabilize and protect eye tissues.

End User:

• Hospitals: Comprise the largest market share as primary sites for ophthalmic surgeries.
• Ophthalmic Clinics: Serve as specialized care centers for eye treatments.
• Others: Include alternative care settings employing these devices.

Regional Insights

North America is the largest market for ophthalmic viscoelastic devices (OVD). The region benefits from extensive research and development activities, a growing geriatric population, and a high prevalence of diabetes and age-related ocular disorders. These factors combine to support sustained market dominance and expansion.

Key Players

• Alcon Inc.
• Altacor Limited
• Bausch Health Companies Inc.
• Bohus Biotech Ab
• Carl Zeiss Meditec Ag
• Cima Technology Inc
• Eyekon Medical Inc.
• Johnson & Johnson
• RUMEX International Co.

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

Request For Customization: https://www.imarcgroup.com/request?type=report&id=6898&flag=E

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us

IMARC Group,

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No: (D) +91 120 433 0800

United States: +1-201971-6302